Back to Results
First PageMeta Content
Clinical research / Pharmacology / Ribbon symbolism / Organofluorides / Benzamides / Prostate cancer / MDV3100 / Triple-negative breast cancer / Breast cancer / Medicine / Chemistry / Organic chemistry


Astellas Contact: Tyler Marciniak Director, Communications and Advocacy[removed]removed]
Add to Reading List

Document Date: 2014-12-10 02:12:33


Open Document

File Size: 121,74 KB

Share Result on Facebook

City

Dublin / San Francisco / Dallas / Barcelona / San Antonio / New York / TOKYO / Memphis / Cambridge / Nashville / Toronto / London / Brussels / Preclinically / Northbrook / /

Company

Tennessee Oncology PLLC / AEs / Astellas Pharma Inc. / Medivation Inc / ITT / Astellas Pharma Global / /

Continent

Europe / /

Country

Belgium / Japan / United States / Canada / United Kingdom / Spain / Ireland / /

Currency

pence / /

/

Event

Business Partnership / FDA Phase / /

Facility

Sunnybrook Health Science Centre / Jules Bordet Institute / Sarah Cannon Research Institute / Memorial Sloan Kettering Cancer Center / University of Tennessee Health Science Center / University of Chicago / Vanderbilt University / Hebron Institute of Oncology / Laboratory Abnormalities / Baylor Charles A Sammons Cancer Center / Mater Misericordiae University Hospital / Harvard University / /

IndustryTerm

pharmaceutical / pharmaceuticals / manufacturing / /

MedicalCondition

loss of consciousness / headache / CNS metastases / advanced AR+ triple-negative breast cancer / nausea / thrombocytopenia / heterogeneous disease / metastatic castration-resistant prostate cancer / fatigue / diarrhea / bone-only non-measurable disease / prostate cancer / constipation / Infections / Breast Cancer / back pain / respiratory tract infection / hypertension / tumors / disease / arthralgia / dyspnea / TRIPLE-NEGATIVE BREAST CANCER TOKYO / neutropenia / vertigo / seizure / vomiting / breast tumors / triple negative breast cancer / stable disease / infection / dizziness / metastases / injuries / /

MedicalTreatment

chemotherapy / /

Organization

Sunnybrook Health Science Centre / Mater Misericordiae University Hospital / Harvard University / Sarah Cannon Research Institute / University of Chicago / Chicago / Hebron Institute of Oncology / University of Tennessee / Jules Bordet Institute / U.S. Food and Drug Administration / Vanderbilt University / Memorial Sloan Kettering Cancer Center / Tennessee Health Science Center / Sammons Cancer Center / /

Person

Tyler Marciniak / /

/

Position

Director / Communications and Advocacy / leader / /

Product

bicalutamide / ENZALUTAMIDE IN ADVANCED / /

ProvinceOrState

Texas / Illinois / New York / Tennessee / California / Ontario / /

Technology

chemotherapy / /

URL

www.XtandiHCP.com/PI / www.astellas.com/en / /

SocialTag